Basit öğe kaydını göster

dc.contributor.authorKaryağar, Savaş
dc.contributor.authorKoç, Zeynep Pınar
dc.contributor.authorKaryağar, Sevda S.
dc.contributor.authorÖztürk, İbrahim
dc.contributor.authorCengiz, Ercüment
dc.contributor.authorSayıcı, Yasin
dc.contributor.authorBalcı, Tansel Ansal
dc.date.accessioned2020-12-19T20:15:56Z
dc.date.available2020-12-19T20:15:56Z
dc.date.issued2013
dc.identifier.citationKaryagar, S., Koc, Z. P., Karyagar, S. S., Öztürk, I., Cengiz, E., Sayc, Y., & Balci, T. A. (2013). Abdominal lymph node metastasis in patients with non-small-cell lung cancer as shown by PET/CT. Clinical nuclear medicine, 38(9), 691–694. https://doi.org/10.1097/RLU.0b013e31829b9beden_US
dc.identifier.issn0363-9762
dc.identifier.urihttps://doi.org/10.1097/RLU.0b013e31829b9bed
dc.identifier.urihttps://hdl.handle.net/11436/4089
dc.description.abstractPurpose: The aim of this study is to investigate the frequency and the spread of abdominal lymph node metastasis in patients with non-small-cell lung cancer (NSCLC) by F-FDG PET/CT. Patients and Methods: Retrospective evaluation of the F-FDG PET/CT examinations of 1191 patients diagnosed with NSCLC was performed. The metastatic abdominal lymph nodes of the patients were classified as inside the routine imaging field (covering the field of chest CT including adrenal glands) and outside the field. Results: Seventy-four patients (6 F, 68 M; mean: 61 ± 11 years old) among 1191 patients (6%) were identified to have abdominal lymph node metastases. These abdominal lymph node metastasis changed management in 10 out of 74 patients (14%), and there were lymph node metastases outside the routine conventional imaging field in 43 (58%) patients. Conclusions: F-FDG PET/CT provided identification of the distant metastatic lymph nodes out of conventional imaging field in more than half of NSCLC patients with abdominal metastasis which changed patient management in 14% of the patients due to abdominal lymph node metastasis outside the routine imaging field. This study shows the necessity of imaging NSCLC patients with an imaging protocol with larger imaging field like PET/CT. © 2013 by Lippincott Williams & Wilkins.en_US
dc.language.isoengen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleAbdominal lymph node metastasis in patients with non-small-cell lung cancer as shown by PET/CTen_US
dc.typearticleen_US
dc.contributor.departmentRTEÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorSayıcı, Yasin
dc.identifier.doi10.1097/RLU.0b013e31829b9bed
dc.identifier.volume38en_US
dc.identifier.issue9en_US
dc.identifier.startpage691en_US
dc.identifier.endpage694en_US
dc.relation.journalClinical Nuclear Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster